腾讯网10 天
默沙东(MRK.US)成人肺炎球菌结合疫苗有望在欧盟获批上市
智通财经APP获悉，默沙东(MRK.US)宣布，欧洲药品管理局(EMA)人用药品委员会(CHMP)已建议批准Capvaxive(21价肺炎球菌结合疫苗)上市，用于对18岁及以上人群的主动免疫，以预防由肺炎链球菌(Streptococcus ...
Managed Healthcare Executive1 天
How Respiratory Microflora Shapes RSV Severity and Long-Term Asthma Risks in Children
The respiratory tract’s microbial microflora plays a significant role in determining the severity of RSV infections and the ...
腾讯网10 天
默沙东研发疫苗有望在欧盟获批上市
▎药明康德内容团队编辑默沙东公司（MSD）日前宣布，欧洲药品管理局（EMA）人用药品委员会（CHMP）已建议批准Capvaxive（21价肺炎球菌结合疫苗）上市，用于对18岁及以上人群的主动免疫，以预防由肺炎链球菌（Streptococcus ...
默沙东成人肺炎球菌结合疫苗有望在欧盟获批上市
默沙东 (MRK.US)宣布，欧洲药品管理局 (EMA)人用药品委员会 (C HM P)已建议批准Capvaxive (21价肺炎球菌结合疫苗)上市，用于对18岁及以上人群的主动免疫，以预防由肺炎链球菌 (Streptococcus pneumoniae)引起的侵袭性疾病和肺炎。
Medindia4 天
Unlocking the Secrets to Childhood Respiratory Infections
‘Are bacteria making #RSV infections worse in kids? Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, ...
EurekAlert!7 天
Why some kids get sicker: The hidden power of nose bacteria
A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...
PMLive8 天
Merck’s adult-specific pneumococcal vaccine Capvaxive recommended by CHMP
The Committee for Medicinal Products for Human Use (CHMP) has recommended that Capvaxive be used to prevent invasive disease ...
Pharmabiz10 天
Merck receives positive EU CHMP opinion for Capvaxive for pneumococcal vaccination in adults
Merck receives positive EU CHMP opinion for Capvaxive for pneumococcal vaccination in adults: Rahway, New Jersey Monday, February 3, 2025, 12:00 Hrs [IST] Merck, known as MSD outs ...
Merck's CAPVAXIVE Gets Positive EU CHMP Opinion For Pneumococcal Vaccination In Adults
Drug major Merck & Co. (MRK) announced Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use or ...